<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2019.10273</article-id>
<article-id pub-id-type="publisher-id">mmr-20-01-0463</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Resveratrol alleviates inflammatory injury and enhances the apoptosis of fibroblast-like synoviocytes via mitochondrial dysfunction and ER stress in rats with adjuvant arthritis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Lu</surname><given-names>Jinsen</given-names></name>
<xref rid="af1-mmr-20-01-0463" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Yongshun</given-names></name>
<xref rid="af2-mmr-20-01-0463" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Yang</surname><given-names>Jiazhao</given-names></name>
<xref rid="af1-mmr-20-01-0463" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Junqiang</given-names></name>
<xref rid="af2-mmr-20-01-0463" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Cao</surname><given-names>Wei</given-names></name>
<xref rid="af2-mmr-20-01-0463" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Xiaoyu</given-names></name>
<xref rid="af2-mmr-20-01-0463" ref-type="aff">2</xref>
<xref rid="c2-mmr-20-01-0463" ref-type="corresp"/></contrib>
<contrib contrib-type="author"><name><surname>Fang</surname><given-names>Shiyuan</given-names></name>
<xref rid="af1-mmr-20-01-0463" ref-type="aff">1</xref>
<xref rid="c1-mmr-20-01-0463" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-20-01-0463"><label>1</label>Department of Orthopedics, Anhui Provincial Hospital, Anhui Medical University, Hefei, Anhui 230001, P.R. China</aff>
<aff id="af2-mmr-20-01-0463"><label>2</label>Department of Histology and Embryology, Anhui Medical University, Hefei, Anhui 230032, P.R. China</aff>
<author-notes>
<corresp id="c1-mmr-20-01-0463"><italic>Correspondence to</italic>: Professor Shiyuan Fang, Department of Orthopedics, Anhui Provincial Hospital, Anhui Medical University, 17 Lujiang Road, Hefei, Anhui 230001, P.R. China, E-mail: <email>fangshiyuan2008@126.com</email></corresp>
<corresp id="c2-mmr-20-01-0463">Professor Xiaoyu Chen, Department of Histology and Embryology, Anhui Medical University, 81 Meishan Road, Hefei, Anhui 230032, P.R. China, E-mail: <email>chenxy@ahmu.edu.cn</email></corresp>
</author-notes>
<pub-date pub-type="ppub"><month>07</month><year>2019</year></pub-date>
<pub-date pub-type="epub"><day>22</day><month>05</month><year>2019</year></pub-date>
<volume>20</volume>
<issue>1</issue>
<fpage>463</fpage>
<lpage>472</lpage>
<history>
<date date-type="received"><day>06</day><month>10</month><year>2018</year></date>
<date date-type="accepted"><day>28</day><month>03</month><year>2019</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; Lu et al.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license>
</permissions>
<abstract>
<p>Resveratrol, a bioactive compound predominantly found in grapes and red wine, provides a wide range of properties that are beneficial for health, including anticancer and anti-inflammatory activities. Previously published studies have addressed the potential therapeutic effects of resveratrol on rheumatoid arthritis (RA); however, the subcellular mechanism remains to be fully elucidated. In the present study, the therapeutic effects of resveratrol on adjuvant arthritis (AA) in Sprague-Dawley rats were investigated, and the mechanisms of resveratrol-induced apoptosis in fibroblast-like synoviocytes (FLSs) were further examined. Based on the findings, resveratrol treatment over a 12-day period led to a reduction in paw swelling and arthritis scores at the macroscopic level, and an attenuation of inflammatory cell infiltration and synovial hyperplasia, upon a histopathological examination of the AA rats. Furthermore, the administration of resveratrol triggered decreases in the expression of interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor-&#x03B1; (TNF-&#x03B1;) and an increase in the expression of IL-10, alleviating inflammatory injury in AA rats in a dose-dependent manner. In addition, resveratrol was revealed to induce the apoptosis of FLSs when administered with 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub> as determined by elevated levels of Bax, caspase-3, caspase-12 and C/EBP-homologous protein, and the downregulation of B-cell lymphoma 2 (Bcl-2), suggesting that resveratrol is able to induce apoptosis in FLSs via the mitochondrial pathway and endoplasmic reticulum (ER) stress in a milieu containing 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. Furthermore, JC-1 was used as a fluorescent probe to detect the mitochondrial membrane potential (&#x0394;&#x03C8;m), and resveratrol was shown to reduce the &#x0394;&#x03C8;m in FLSs in the presence of 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. However, resveratrol was not able to trigger intracellular calcium overload, although it did suppress ATP- and thapsigargin-induced calcium release from the ER. In conclusion, the present study revealed that resveratrol was able to alleviate inflammatory injury in AA rats, triggering the apoptosis of FLSs via the mitochondrial pathway and ER stress. These results provide a theoretical basis for future treatments using resveratrol for RA.</p>
</abstract>
<kwd-group>
<kwd>resveratrol</kwd>
<kwd>apoptosis</kwd>
<kwd>mitochondrial dysfunction</kwd>
<kwd>endoplasmic reticulum stress</kwd>
<kwd>fibroblast synovialcytes</kwd>
<kwd>adjuvant arthritis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Rheumatoid arthritis (RA), an immune-mediated inflammatory disease of connective tissue, chronically accelerates the erosion of cartilage and subchondral bone, characterized by symmetrical inflammation in the joints of the hands and feet (<xref rid="b1-mmr-20-01-0463" ref-type="bibr">1</xref>,<xref rid="b2-mmr-20-01-0463" ref-type="bibr">2</xref>). Hyperplasia of fibroblast-like synoviocytes (FLSs) in pannus, the aggressive front of synovial tissue, accompanied by the mass infiltration of macrophages and lymphocytes, are the typical features of the pathogenesis in RA (<xref rid="b3-mmr-20-01-0463" ref-type="bibr">3</xref>). Inflammatory and anti-inflammatory mediators exert significant effects in the pathogenesis of RA (<xref rid="b4-mmr-20-01-0463" ref-type="bibr">4</xref>&#x2013;<xref rid="b6-mmr-20-01-0463" ref-type="bibr">6</xref>). Previous studies have demonstrated that the enhanced proliferation and attenuated apoptosis of FLSs contribute to the invasion and destruction of connective tissue by pannus in joints (<xref rid="b7-mmr-20-01-0463" ref-type="bibr">7</xref>,<xref rid="b8-mmr-20-01-0463" ref-type="bibr">8</xref>). Through the persistent efforts of investigators, a number of natural and synthetic anti-inflammatory and anticancer drugs have been found to suppress the abnormal proliferation of FLSs in patients with RA, or in adjuvant arthritis (AA) model rats (<xref rid="b9-mmr-20-01-0463" ref-type="bibr">9</xref>&#x2013;<xref rid="b12-mmr-20-01-0463" ref-type="bibr">12</xref>).</p>
<p>Resveratrol, a bioactive compound predominantly found in grapes and red wine, provides a wide range of properties that are beneficial for health, including anticancer, anti-inflammatory, antioxidant and cardiovascular protective activities (<xref rid="b13-mmr-20-01-0463" ref-type="bibr">13</xref>). Furthermore, it has been suggested that resveratrol may not only suppress proliferation, but may also induce apoptosis in various types of cancer, including myeloid, breast, lung, liver, pancreatic, prostate, colon and skin cancer (<xref rid="b14-mmr-20-01-0463" ref-type="bibr">14</xref>&#x2013;<xref rid="b16-mmr-20-01-0463" ref-type="bibr">16</xref>). The mechanism by which resveratrol exerts its pro-apoptotic activities involves a wide range of signaling pathways, including the mitochondrial, caspase 8- or 9-dependent, receptor-dependent pathways and cell cycle arrest. Resveratrol-induced apoptosis has also been demonstrated to be associated with the B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax)/Bcl-2 ratio, driven by changes in the transcriptional activity of P53 and nuclear factor-&#x03BA;B (<xref rid="b15-mmr-20-01-0463" ref-type="bibr">15</xref>,<xref rid="b17-mmr-20-01-0463" ref-type="bibr">17</xref>). A previous study indicated that reactive oxygen species (ROS) can function as upstream signaling molecules that exert an influence on endoplasmic reticulum (ER) stress-mediated apoptosis (<xref rid="b18-mmr-20-01-0463" ref-type="bibr">18</xref>). In addition, overexpressed ROS are able to induce the dysfunction of ER foldase and chaperones, leading to an accumulation of unfolded protein, reduced protein biosynthesis and alleviation of the burden of the ER, which may afford a protective response (<xref rid="b19-mmr-20-01-0463" ref-type="bibr">19</xref>). However, continuous and marked ER stress may lead to a prolonged period of marked C/EBP homologous protein (Chop) expression, steering the cells towards apoptosis (<xref rid="b20-mmr-20-01-0463" ref-type="bibr">20</xref>,<xref rid="b21-mmr-20-01-0463" ref-type="bibr">21</xref>). In our previous study, it was demonstrated that levels of mitochondrial ROS and apoptosis were elevated following resveratrol treatment in FLSs (<xref rid="b22-mmr-20-01-0463" ref-type="bibr">22</xref>). Based on the close biological association of mitochondria with the ER, the pro-apoptotic effects of resveratrol may correlate with mitochondrial dysfunction and ER stress. Furthermore, excessive ROS may trigger the oxidative modification of ER proteins and suppress the Ca<sup>2&#x002B;</sup>-ATPase, leading to the depletion of calcium stores and cell apoptosis, as revealed in hypoxic-ischemic model rats (<xref rid="b21-mmr-20-01-0463" ref-type="bibr">21</xref>). Cytokines are vital agents in the inflammatory process. Markedly pro-inflammatory cytokines, including interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor-&#x03B1; (TNF-&#x03B1;), combined with markedly anti-inflammatory IL-10, are ideal markers to assess the properties of resveratrol and its influence on immune responses (<xref rid="b4-mmr-20-01-0463" ref-type="bibr">4</xref>&#x2013;<xref rid="b6-mmr-20-01-0463" ref-type="bibr">6</xref>).</p>
<p>Considering the experimental evidence amassed to date, resveratrol may be considered as a potential alleviator of the symptoms of RA for patients, although its specific effects on FLSs and the underlying mechanism remain to be elucidated. The present study aimed to further investigate the pro-apoptotic mechanism of resveratrol on FLSs with respect to mitochondrial and ER dysfunction.</p>
</sec>
<sec sec-type="materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Animal groupings and model evaluation</title>
<p>A total of 60 2-month-old male Sprague-Dawley (SD) rats (180&#x00B1;20 g) were obtained from the Laboratory Animal Center of Anhui Medical University (Hefei, China). The present study was approved by the Medical Ethics Committee of the Academic Committee at Anhui Medical University. The animals were acclimatized in a room at constant temperature (22&#x2013;23&#x00B0;C) under a 12-h light-dark cycle (light on at 7:00 AM), and the relative humidity was controlled within the range 50&#x2013;70&#x0025;. The rats were provided with access to standard mice chow and water <italic>ad libitum</italic>. Aliquots of 150 &#x00B5;l Freund&#x0027;s complete adjuvant (FCA; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) were injected into the left hind toe of the male SD rats once, and evident arthritis was observed 20 days later. Control rats were injected with 150 &#x00B5;l physiological saline in the identical region of the limb. Subsequently, the AA model rats were randomly divided into five groups that were respectively treated with 0, 5, 15 or 45 mg/kg resveratrol and 200 mg/kg N-acetyl-L-cysteine (NAC; Merck KGaA) for 12 days by continuous intragastric administration. The selection of the doses used in the present study were based on a study described previously (<xref rid="b23-mmr-20-01-0463" ref-type="bibr">23</xref>). All animals were sacrificed on the 12th day upon completion of the above-mentioned treatments. Blood samples were centrifuged at 1,500 &#x00D7; g for 20 min at &#x2212;4&#x00B0;C to obtain the supernatant fluid, which was stored at &#x2212;80&#x00B0;C prior to further analysis. The degree of paw swelling and the arthritis index scores were determined to evaluate the severity of AA. Following the injection of the FCA emulsion, the hind paw volume (ml) of all rats was measured using a plethysmometer at 3-day intervals. The arthritis index was classified using a four-points scale (0 points, red spots or mild swelling; 2 points, moderate joint swelling; 3 points, severe joint swelling; 4 points, joint rigidity, deformity or severe dysfunction), totaling 16 points for each rat. The degree of paw swelling was also used to evaluate the severity of the lesion in the affected limb. Prior to the induction of inflammation, an animal volume detector (Jinan Yanyi Biotechnology Corporation, Jinan, China) was applied to detect the affected hind paw volume of each rat (F0). From the onset of inflammation, the left hind paw volume was measured every 4 days (F1), and the degree of paw swelling of the affected paw was calculated according to F1/F0.</p>
</sec>
<sec>
<title>Cell culture and isolation</title>
<p>FLSs were isolated from the rats in the AA model group as described previously (<xref rid="b24-mmr-20-01-0463" ref-type="bibr">24</xref>). Sterile synovial tissue samples were separated into 1-mm<sup>3</sup>-sized pieces, mixed with twice the volume of 0.2&#x0025; type II collagenase (Merck KGaA) containing 10&#x0025; Gibco<sup>&#x00AE;</sup> fetal bovine serum (FBS; Thermo Fisher Scientific, Inc., Waltham, MA, USA), and the tissues were digested for 2&#x2013;2.5 h at 25&#x00B0;C (percussing the samples once every 30 min). Finally, 0.25&#x0025; trypsin was added for a further digestion step for 30 min, and the isolated FLSs were cultured in Gibco<sup>&#x00AE;</sup> Dulbecco&#x0027;s modified Eagle medium (Thermo Fisher Scientific, Inc.) supplemented with 15&#x0025; FBS in an incubator at 37&#x00B0;C with 5&#x0025; CO<sub>2</sub> prior to performing the following experiments.</p>
</sec>
<sec>
<title>Evaluation of inflammatory injury, apoptosis and intracellular ROS</title>
<p>Blood from the AA rats was obtained via removal of the eyes, and serum was isolated via centrifugation (2,000 &#x00D7; g) at 4&#x00B0;C for 20 min. Serum levels of IL-1, IL-6, IL-8, IL10 and TNF-&#x03B1; were detected using ELISA kits (all Abcam, Cambridge, MA, USA) for mouse IL-1 (cat. no. ab100704), IL-6 (cat. no. ab100712), IL-8 (cat. no. ab46032), IL10 (cat. no. ab108870) and TNF-&#x03B1; (cat. no. ab208348) according to the manufacturer&#x0027;s protocol. Cell apoptosis was detected using a terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling (TUNEL) assay (Roche Diagnostics, Indianapolis, IN, USA) <italic>in situ</italic> cell death detection kit (cat. no. 11684817910), according to the manufacturer&#x0027;s protocol. Briefly, FLSs were washed 3 times with phosphate-buffered saline (PBS) and incubated with reaction buffer at 37&#x00B0;C for 30 min in the dark. FLS were then stained with DAPI at room temperature for 5 min in the dark to visualize the nuclei, following which slices were mounted (cat. no. ab64230; Abcam) at room temperature for ~5 min. The number of apoptotic cells, and the total numbers of cells, were counted from five random fields in each slide under a light microscope (magnification, &#x00D7;200). The results are presented as the ratio of the apoptotic cell number to the total cell number (n=3 for each group) (<xref rid="b25-mmr-20-01-0463" ref-type="bibr">25</xref>).</p>
<p>Apoptosis-associated proteins, including Bcl-2, caspase-3, Bax, caspase-12 and Chop, were detected via western blot analysis according to a protocol described previously (<xref rid="b23-mmr-20-01-0463" ref-type="bibr">23</xref>). Briefly, cells were lysed using RIPA buffer (Beyotime Institute of Technology, Shanghai, China) and centrifuged at 12,000 &#x00D7; g for 10 min at 4&#x00B0;C. The protein concentration was determined using a BCA Protein Assay kit (cat. no. P0011; Beyotime Institute of Technology). The supernatants were degenerated via heating at 100&#x00B0;C for 5 min with 1/5 volume of loading buffer (Beyotime Institute of Technology), and 30 &#x00B5;g samples were loaded in each well, separated via 10&#x0025; SDS-PAGE and transferred to PVDF membranes (EMD Millipore, Billicera, MA, USA). Next, 5&#x0025; nonfat milk in washing buffer was used to block the PVDF membranes for 2 h at room temperature, which were then incubated at 4&#x00B0;C overnight with primary antibodies (all from Abcam) specific for Bax (1:1,500; cat. no. ab32503), Bcl-2 (1:2,000; cat. no. ab182858), caspase-3 (1:2,000; cat. no. ab13847), caspase-12 (1:2,500; cat. no. ab62484), Chop (1:3,000; cat. no. ab179823) and &#x03B2;-actin (1:10,000; cat. no. ab115777). On the following day, membranes were washed and incubated with horseradish peroxidase-conjugated anti-rabbit Immunoglobulin G secondary antibody (1:10,000; cat. no. A0208; Beyotime Institute of Biotechnology) for 1 h at room temperature. Finally, protein bands were visualized using enhanced chemiluminescence reagent (Boster Biological Technology, Pleasanton, CA, USA), imaged using a Gel-Dox XR&#x002B; imager (Bio-Rad Laboratories, Inc., Hercules, CA, USA) and quantified using Image Lab v4.0 (Bio-Rad Laboratories, Inc.).</p>
<p>2&#x2032;,7&#x2032;-Dichlorodihydrofluorescein diacetate (DCFH-DA) was utilized as the fluorescent probe to detect intracellular ROS in the FLSs, also according to the manufacturer&#x0027;s protocol (Bioluminor Biotechnology Co., Ltd., Xiamen, Fujian, China). Briefly, 1&#x00D7;10<sup>5</sup>/cm<sup>2</sup> FLSs grown on glass coverslips were cultured with 5 &#x00B5;M DCFH-DA at 37&#x00B0;C for 20 min. Following staining, the slides were rinsed three times with PBS. Subsequently, the fluorescence intensity was determined using a confocal laser scanning microscope (Leica SP5-DMI6000-DIC; Leica Microsystems GmbH, Wetzlar, Germany); its in-built evaluation software (Leica LAS AF Lite 2.6.0 build 7288) was used to detect the quantitative analysis of the green fluorescence signal with an excitation wavelength of 488 nm and an emission wavelength of 522 nm. The ROS level was positively correlated with fluorescent intensity.</p>
</sec>
<sec>
<title>Hematoxylin and eosin (H&#x0026;E) staining</title>
<p>Following corresponding animal experiments, the rats were sacrificed via cervical dislocation. The knee joint was extracted and fixed in 4&#x0025; paraformaldehyde at 4&#x00B0;C. Subsequently, the tissues were dehydrated in ethanol and finally embedded in paraffin. Histologic cuts from the paraffin blocks (5-mm thickness) were obtained and stained with hematoxylin and eosin as previously described (<xref rid="b22-mmr-20-01-0463" ref-type="bibr">22</xref>). Briefly, the sections were attached to the slide and heated at 60&#x00B0;C. Next, the sections were dewaxed with xylene twice for 5 min, rehydrated in a graded ethanol series and then distilled water for 3 min, and then stained with hematoxylin for 5 min and with eosin for 20 sec (both steps at room temperature). Sections were then dehydrated in a graded ethanol series and subsequently incubated with xylene for 5 min. Finally, sections were sealed with neutral paraffin. The images of the stained tissue were captured via a light microscope (magnification, &#x00D7;100 and &#x00D7;400). A total of six fields were randomly selected from each group, and the fields of view were analyzed by two different observers.</p>
</sec>
<sec>
<title>Mitochondrial membrane potential (&#x0394;&#x03C8;m) determination</title>
<p>According to the manufacturer&#x0027;s protocol, a &#x0394;&#x03C8;m assay kit with JC-1 (Thermo Fisher Scientific, Inc.) was used to detect &#x0394;&#x03C8;m. In terms of the functioning of the assay, the JC-1 probe accumulates in the mitochondrial matrix to form a polymer, which results in marked red fluorescence in normal mitochondria; however, the JC-1 probe exists as a monomer in damaged mitochondria, and appears as marked green fluorescence. Following the specific experimental treatments with resveratrol and H<sub>2</sub>O<sub>2</sub>, 1&#x00D7;10<sup>5</sup>/cm<sup>2</sup> FLSs, grown on glass coverslips, were cultured with 5 &#x00B5;g/ml JC-1 at 37&#x00B0;C for 20 min. Following staining, the slides were rinsed three times with PBS. As described above, the fluorescence intensity was subsequently determined using a Leica SP5-DMI6000-DIC confocal laser scanning microscope (Leica Microsystems GmbH), and its in-built evaluation software (Leica LAS AF Lite) was used to detect the quantitative analysis of the green fluorescence signal, with an excitation wavelength of 507 nm and an emission wavelength of 529 nm. Measurements for &#x0394;&#x03C8;m were determined as the ratios of red-to-green fluorescence intensity.</p>
</sec>
<sec>
<title>Intracellular calcium [(Ca2&#x002B;)i] measurement</title>
<p>The measurement of [Ca<sup>2&#x002B;</sup>]<sub>i</sub> was performed as previously described (<xref rid="b26-mmr-20-01-0463" ref-type="bibr">26</xref>). Briefly, 1&#x00D7;10<sup>5</sup>/cm<sup>2</sup> FLSs were seeded on circular coverslips and incubated with 10 &#x00B5;mol/l Fluo-8 combined with 0.02&#x0025; pluronic acid F-127 at 37&#x00B0;C for 20 min. Ca<sup>2&#x002B;</sup> release was triggered via treating FLSs with 4 &#x00B5;mol/l thapsigargin (TG) or 100 &#x00B5;mol/l ATP for 5 min in Ca<sup>2&#x002B;</sup>-free PBS containing 140 mmol/l NaCl, 5 mmol/l KCl, 1 mmol/l MgCl<sub>2</sub>, 10 mmol/l glucose, 0.2 mmol/l EGTA and 5 mmol/l 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid (pH 7.4). Real-time fluctuations in fluorescence representing [Ca<sup>2&#x002B;</sup>]<sub>i</sub> (the internal concentration of Ca<sup>2&#x002B;</sup>) were recorded using a Leica SP5-DMI6000-DIC confocal laser scanning microscope (Leica Microsystems GmbH) with an excitation wavelength of 488 nm and a long-pass emission wavelength of 515 nm. Variations in [Ca<sup>2&#x002B;</sup>]<sub>i</sub> are shown as the ratio of fluorescence relative to the intensity prior to the administration of TG or ATP (F1/F0). The fluorescence intensities were measured, based on an average of 20&#x2013;30 cells for each measurement.</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>The results were analyzed using SPSS 19.0 statistical software (IBM Corp., Armonk, NY, USA), and data are shown as the mean &#x00B1; standard deviation of experiments performed in triplicate. All datasets were analyzed using one-way analysis of variance followed by Tukey&#x0027;s post hoc test to compare two groups. P&#x2264;0.05 was considered to indicate a statistically significant difference.</p>
</sec>
</sec>
</sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Resveratrol attenuates the severity of arthritis induced by adjuvant in AA rats</title>
<p>Following the injection of FCA in SD rats, marked paw swelling was observed. In order to identify the association between the dose and pharmacological action of resveratrol, three experimental groups, treated with low (5 mg/kg), middle (15 mg/kg) and high (45 mg/kg) doses of resveratrol, were established in the present study (<xref rid="b23-mmr-20-01-0463" ref-type="bibr">23</xref>,<xref rid="b27-mmr-20-01-0463" ref-type="bibr">27</xref>). NAC, the precursor of reduced glutathione, is an important non-enzymatic antioxidant in the cell that eliminates reactive oxygen groups, and has been demonstrated to be effective in suppressing AA and RA. Therefore, NAC was applied as a positive control in order to examine the functional role of resveratrol (<xref rid="b28-mmr-20-01-0463" ref-type="bibr">28</xref>&#x2013;<xref rid="b30-mmr-20-01-0463" ref-type="bibr">30</xref>). Compared with the AA model group, treatment with resveratrol markedly reduced paw swelling and the arthritis score in AA rats (<xref rid="f1-mmr-20-01-0463" ref-type="fig">Fig. 1A and B</xref>). In addition, the effects of resveratrol on AA rats were further demonstrated by H&#x0026;E staining. FCA injection triggered mass mononuclear cell infiltration, and hyperplasia of synovial tissue. Upon microscopic examination, eroded cartilage and thickened synovial tissue were clearly observed, with a large number of fragments gathered in the synovial cavity of the AA model group. Following treatment with resveratrol, the synovial samples from rats revealed evidently attenuated inflammatory cell infiltration and synovial hyperplasia; however, all the above symptoms were relieved, or even eliminated, compared with the AA model group (<xref rid="f1-mmr-20-01-0463" ref-type="fig">Fig. 1C</xref>).</p>
</sec>
<sec>
<title>Resveratrol alleviates inflammatory injury in AA rats</title>
<p>The rats in the respective groups were fed for 27 days, and subsequently received intragastric administration of 5, 15 or 45 mg/kg resveratrol and 200 mg/kg NAC for 12 days. Subsequently, the serum levels of IL-1, IL-6, IL-8, IL-10 and TNF-&#x03B1; were detected using ELISA assay. Administration of resveratrol led to a marginal decrease in the levels of IL-1, IL-6, IL-8 and TNF-&#x03B1;, although the level of IL-10 in AA rats was increased compared with that in the non-immunized controls in a dose-dependent manner. This indicated that resveratrol was able to reduce the level of inflammatory injury in the AA rats (<xref rid="f2-mmr-20-01-0463" ref-type="fig">Fig. 2A-E</xref>). Among the three experimental groups treated with resveratrol, administration of 45 mg/kg resveratrol exhibited the most marked suppression, which approached the level of normal controls.</p>
</sec>
<sec>
<title>Resveratrol induces apoptosis of FLSs within a 5&#x00B5;M H<sub>2</sub>O<sub>2</sub> environment</title>
<p>Considering the anti-inflammatory and anticancer effects of resveratrol reported previously in the literature, the hypothesis of the present study was that resveratrol triggers the apoptosis of FLSs. In order to test this hypothesis, a TUNEL assay was used to examine the apoptotic rate of the FLSs. As shown in <xref rid="f2-mmr-20-01-0463" ref-type="fig">Fig. 2F and G</xref>, no evident differences in the apoptotic rates were observed when comparing between the normal controls and FLSs; only when the cells were incubated with 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub> did treatment with resveratrol lead to an evident increase in the apoptotic rate, and this increase occurred in a dose-dependent manner. Subsequently, DCFH-DA was utilized to assess the levels of intracellular ROS, and these results demonstrated that resveratrol led to an increase in the level of intracellular ROS in FLSs in a dose-dependent manner, and therefore it may be potential marker for apoptosis and ER stress (<xref rid="f2-mmr-20-01-0463" ref-type="fig">Fig. 2H</xref>).</p>
</sec>
<sec>
<title>Mitochondrial dysfunction is involved in the process of resveratrol-induced apoptosis in FLSs</title>
<p>As resveratrol induced the apoptosis of FLSs in an environment containing 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub>, further elucidation of the intracellular mechanism became the subsequent objective. It has been well established that the mitochondrial signaling pathway has a vital role in cell apoptosis (<xref rid="b31-mmr-20-01-0463" ref-type="bibr">31</xref>). In order to examine whether the mitochondrial signaling pathway is involved in resveratrol-induced apoptosis, the expression levels of mitochondria-associated apoptotic proteins were initially examined. The immunoblotting results suggested that, in the presence of 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub> treatment, resveratrol led to a notable increase in the expression levels of pro-apoptotic proteins, including Bax and active caspase-3, whereas the anti-apoptotic protein, Bcl-2, was evidently suppressed compared with that in normal control cells and FLSs treated only with 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub> (<xref rid="f3-mmr-20-01-0463" ref-type="fig">Fig. 3C-F</xref>).</p>
<p>A reduction in &#x0394;&#x03C8;m or enhanced mitochondrial membrane depolarization have been demonstrated to provide an early sign of cell apoptosis, even in advance of DNA damage (<xref rid="b32-mmr-20-01-0463" ref-type="bibr">32</xref>). JC-1, a widely used fluorescent probe to detect &#x0394;&#x03C8;m, forms aggregates in the mitochondrial matrix that yield red florescence when the value of &#x0394;&#x03C8;m is relatively high, whereas it forms monomers, giving rise to green florescence, when the value of &#x0394;&#x03C8;m is comparatively low (<xref rid="b33-mmr-20-01-0463" ref-type="bibr">33</xref>). As shown in <xref rid="f3-mmr-20-01-0463" ref-type="fig">Fig. 3A and B</xref>, resveratrol was able to suppress the ratio of the red-to-green fluorescent intensity in FLSs in the presence of 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub> in a dose-dependent manner compared with normal control cells and FLSs treated only with 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub>, indicating that resveratrol was able to lead to a reduction in &#x0394;&#x03C8;m, which further confirmed the pro-apoptotic effects of resveratrol.</p>
</sec>
<sec>
<title>Suppression of [Ca<sup>2&#x002B;</sup>]<sub>i</sub> release and ER stress in FLSs are involved in the resveratrol-induced apoptosis of FLSs</title>
<p>Apart from the mitochondria-associated apoptotic pathway, the ER, which is known as an intracellular Ca<sup>2&#x002B;</sup> store, also serves a crucial role in cell apoptosis. Previous reports have indicated that the depletion of ER Ca<sup>2&#x002B;</sup> stores may trigger cell apoptosis and growth arrest (<xref rid="b34-mmr-20-01-0463" ref-type="bibr">34</xref>,<xref rid="b35-mmr-20-01-0463" ref-type="bibr">35</xref>), and the hypothesis of the present study was that resveratrol may affect the depletion of the Ca<sup>2&#x002B;</sup> store. As Ca<sup>2&#x002B;</sup> stores may be depleted by both ATP and TG, the effect of resveratrol on TG- and ATP-induced Ca<sup>2&#x002B;</sup> release from the ER Ca<sup>2&#x002B;</sup> stores was subsequently examined (<xref rid="b36-mmr-20-01-0463" ref-type="bibr">36</xref>,<xref rid="b37-mmr-20-01-0463" ref-type="bibr">37</xref>). Unexpectedly, the calcium imaging experiments revealed that higher doses of resveratrol led to a suppression of TG- and ATP-induced Ca<sup>2&#x002B;</sup> release in FLSs in an environment containing 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub> (<xref rid="f4-mmr-20-01-0463" ref-type="fig">Fig. 4A-D</xref>). By contrast, continuous and heavily applied ER stress has been suggested to be another possible means of inducing cell apoptosis (<xref rid="b38-mmr-20-01-0463" ref-type="bibr">38</xref>). Two essential terminal apoptosis-associated proteins located downstream of the ER stress pathway, Chop and caspase-12, have been revealed to be elevated under aggravated ER stress (<xref rid="b39-mmr-20-01-0463" ref-type="bibr">39</xref>). In the present study, the immunoblotting data obtained revealed that resveratrol led to an increase in the expression levels of Chop and caspase-12 in FLSs in the presence of 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub>, in a dose-dependent manner, compared with levels in normal control cells and FLSs treated only with 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub> (<xref rid="f4-mmr-20-01-0463" ref-type="fig">Fig. 4E-G</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>In the present study, AA model rats were utilized to examine the features of RA. Resveratrol injection led to an evident reduction in the levels of IL-1, IL-6, IL-8 and TNF-&#x03B1;, and an increase in the level of IL-10 in AA rats compared with levels in non-immunized controls in a dose-dependent manner, indicating that resveratrol was able to reduce the level of inflammatory injury, and to enhance the anti-inflammatory capability, in AA rats. RA is an autoimmune disease of the connective tissue characterized by disrupted serum levels of inflammatory cytokines, including IL-1, IL-6, IL-8 and TNF-&#x03B1;, which occur during its pathogenesis. The results of the present study further corroborate the therapeutic effects of resveratrol on RA identified in previous studies of others (<xref rid="b4-mmr-20-01-0463" ref-type="bibr">4</xref>&#x2013;<xref rid="b6-mmr-20-01-0463" ref-type="bibr">6</xref>). Cytokines are vital agents in the inflammatory process. The markedly pro-inflammatory cytokines, IL-1, IL-6, IL-8 and TNF-&#x03B1;, together with the markedly anti-inflammatory cytokine, IL-10, were selected for assessment of the properties of resveratrol and its influence on immune responses. Resveratrol is a multifunctional compound, which reduced the serum levels of IL-1, IL-6, IL-8 and TNF-&#x03B1; and simultaneously increased the level of IL-10. It is an important marker in the investigation to identify an effective pharmacological treatment of RA based on the inflammatory etiology. Furthermore, the intragastric administration of resveratrol potently reduced paw swelling, the arthritis score, inflammatory cell infiltration and synovial hyperplasia in AA rats compared with the AA model group (<xref rid="f1-mmr-20-01-0463" ref-type="fig">Fig. 1D</xref>). Accumulating evidence that resveratrol possesses certain tumor-like properties has previously been reported, based on the fact that it not only suppresses the proliferation of, but also induces apoptosis in various cancer cell types and FLSs (<xref rid="b22-mmr-20-01-0463" ref-type="bibr">22</xref>). Based on our former findings, the proliferation of FLSs was identified as a typical abnormality in RA, and 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub> was identified as the optimal concentration for treatment; this concentration achieved the highest proliferative rate of FLSs compared with higher or lower doses of H<sub>2</sub>O<sub>2</sub>, and simulated the physiological conditions of oxidative stress in AA model rats (<xref rid="b22-mmr-20-01-0463" ref-type="bibr">22</xref>).</p>
<p>The results of the <italic>in vitro</italic> TUNEL assay revealed that the administration of resveratrol triggered the apoptosis of FLSs in the presence of 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub>, and the apoptotic rate was increased with increasing doses of resveratrol. As the majority of ROS are produced in mitochondria, and resveratrol was able to reduce excessive ROS production, it was hypothesized that the mitochondrial apoptotic pathway may be involved in the resveratrol-induced apoptosis of FLSs treated with 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. The levels of pro-apoptotic members of the Bcl family, including Bax and caspase-3, were increased, whereas that of the anti-apoptotic protein, Bcl-2, was suppressed following administration of resveratrol in FLSs treated with 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. Furthermore, a reduced &#x0394;&#x03C8;m is known to provide an early indicator for cellular apoptosis, and decreased &#x0394;&#x03C8;m levels were detected upon treatment of resveratrol with 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub>.</p>
<p>Apart from the mitochondrial pathway, ER stress may also be involved in the progression of apoptosis. An increasing number of studies have revealed that ER stress, which refers to a particular type of subcellular pathological state of ER that is characterized by calcium dyshomeostasis, accumulation of unfolded proteins, and ER dysfunction caused by intracellular and extracellular stimuli, including viral infection and glucose deficiency, serves vital roles in the process of cell apoptosis (<xref rid="b18-mmr-20-01-0463" ref-type="bibr">18</xref>). During the process of ER stress, the unfolded protein reaction mediated by chaperone-glucose-regulated protein 78/binding immunoglobulin protein and three stress sensors, namely PKR-like ER kinase, activating transcription factor 6 and inositol-requiring enzyme 1, exert a protective role via reducing the accumulation of unfolded protein, and gradually restoring the normal function of ER (<xref rid="b40-mmr-20-01-0463" ref-type="bibr">40</xref>). However, continual and heavily applied ER stress can activate the downstream apoptotic signaling molecules, Chop and caspase-12, leading to cell apoptosis (<xref rid="b20-mmr-20-01-0463" ref-type="bibr">20</xref>,<xref rid="b41-mmr-20-01-0463" ref-type="bibr">41</xref>). In the present study, the levels of these two essential mediators of ER stress-associated apoptosis, Chop and caspase-12, were elevated following treatment with resveratrol in the presence of 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. As the most important calcium store, ER undertakes vital tasks in maintaining the normal biological activity of the cells, and calcium overload is often linked to ER-associated apoptosis. However, the processes of TG- and ATP-induced calcium release were marginally suppressed following the administration of resveratrol with 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub>. This may due to a reduction in the activity of ion channels that mediate the outflow of calcium ions elicited by resveratrol; it is noteworthy that these results were inconsistent with a former study, in which ATP-induced apoptosis was accompanied by an elevated rate of calcium release in HN4 cells (<xref rid="b42-mmr-20-01-0463" ref-type="bibr">42</xref>). In the present study, TG and ATP were used to induce calcium depletion of ER via diverse mechanisms. TG prevents intracellular calcium from flowing into the ER by blocking the sarco/endoplasmic reticulum Ca<sup>2&#x002B;</sup>-ATPase (SERCA), leading to a one-way efflux of calcium from the ER to the cytosol. ATP binds to the purinergic receptor (P2Y or P2X) on the cell membrane, and subsequently couples with phospholipase C (PLC), leading to activation of the inositol 1,4,5-trisphosphate receptor on the ER, which subsequently leads to an emptying of the calcium pool (<xref rid="b24-mmr-20-01-0463" ref-type="bibr">24</xref>). Therefore, the suppressive effects of calcium release mediated by resveratrol in FLSs may be associated with an activation of SERCA and inhibition of the P2Y/PLC/IP3 pathway, although this hypothesis requires further confirmation.</p>
<p>In conclusion, the present study demonstrated that resveratrol was able to suppress the level of inflammatory injury in AA and to trigger the apoptosis of FLSs through the mitochondrial pathway and ER stress in the presence of 5 &#x00B5;M H<sub>2</sub>O<sub>2</sub>, thereby alleviating the symptoms of AA in SD rats (<xref rid="f5-mmr-20-01-0463" ref-type="fig">Fig. 5</xref>). However, the effects of resveratrol on the bioactivity of ER-located calcium channels require further investigation, and whether or not other forms of programmed cell death may be involved in this progress remains to be elucidated.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors would like to thank Professor Bing Shen (Department of Physiology of Anhui Medical University), who instructed on aspects of this study and who provided the [Ca<sup>2&#x002B;</sup>] measurements.</p>
</ack>
<sec>
<title>Funding</title>
<p>This study was supported by a grant from the National Natural Science Foundation of China (grant nos. NSFC:81373421 and 81270650).</p>
</sec>
<sec>
<title>Availability of data and materials</title>
<p>The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>JSL, SYF and XYC designed the experiments. JSL and YSZ performed the experiments. JSL and JZY conducted the data analysis. JQZ and WC contributed to data acquisition and analysis. JSL drafted the manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>The animal experiments was approved by the Medical Ethics Committee of the Academic Committee at Anhui Medical University. No human experiments were included in the present study.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-mmr-20-01-0463"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellucci</surname><given-names>E</given-names></name><name><surname>Terenzi</surname><given-names>R</given-names></name><name><surname>La Paglia</surname><given-names>GM</given-names></name><name><surname>Gentileschi</surname><given-names>S</given-names></name><name><surname>Tripoli</surname><given-names>A</given-names></name><name><surname>Tani</surname><given-names>C</given-names></name><name><surname>Alunno</surname><given-names>A</given-names></name></person-group><article-title>One year in review 2016: Pathogenesis of rheumatoid arthritis</article-title><source>Clin Exp Rheumatol</source><volume>34</volume><fpage>793</fpage><lpage>801</lpage><year>2016</year><pub-id pub-id-type="pmid">27716458</pub-id></element-citation></ref>
<ref id="b2-mmr-20-01-0463"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Yamamoto</surname><given-names>K</given-names></name></person-group><article-title>From genetics to functional insights into rheumatoid arthritis</article-title><source>Clin Exp Rheuma 33 (4 Suppl 92)</source><fpage>S40</fpage><lpage>S43</lpage><year>2015</year></element-citation></ref>
<ref id="b3-mmr-20-01-0463"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>GC</given-names></name><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Cho</surname><given-names>WS</given-names></name><name><surname>Lee</surname><given-names>SG</given-names></name><name><surname>Jeong</surname><given-names>M</given-names></name><name><surname>Cho</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name></person-group><article-title>Apigenin-induced apoptosis is mediated by reactive oxygen species and activation of ERK1/2 in rheumatoid fibroblast-like synoviocytes</article-title><source>Chem Biol Interact</source><volume>182</volume><fpage>29</fpage><lpage>36</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.cbi.2009.07.016</pub-id><pub-id pub-id-type="pmid">19647729</pub-id></element-citation></ref>
<ref id="b4-mmr-20-01-0463"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>NR</given-names></name><name><surname>Lim</surname><given-names>MA</given-names></name><name><surname>Kim</surname><given-names>SM</given-names></name><name><surname>Hwang</surname><given-names>SH</given-names></name><name><surname>Jung</surname><given-names>KA</given-names></name><name><surname>Choi</surname><given-names>J</given-names></name><name><surname>Park</surname><given-names>SH</given-names></name><name><surname>Cho</surname><given-names>ML</given-names></name></person-group><article-title>Deficiency of IL-1 receptor antagonist suppresses IL-10-producing B cells in autoimmune arthritis in an IL-17/Th17-dependent manner</article-title><source>Immunol Lett</source><volume>199</volume><fpage>44</fpage><lpage>52</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.imlet.2018.05.003</pub-id><pub-id pub-id-type="pmid">29803636</pub-id></element-citation></ref>
<ref id="b5-mmr-20-01-0463"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>S</given-names></name><name><surname>Tran</surname><given-names>TH</given-names></name><name><surname>Amiji</surname><given-names>M</given-names></name></person-group><article-title>Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis</article-title><source>Biomaterials</source><volume>61</volume><fpage>162</fpage><lpage>177</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.biomaterials.2015.05.028</pub-id><pub-id pub-id-type="pmid">26004232</pub-id><pub-id pub-id-type="pmcid">4464978</pub-id></element-citation></ref>
<ref id="b6-mmr-20-01-0463"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandpur</surname><given-names>R</given-names></name><name><surname>Carmona-Rivera</surname><given-names>C</given-names></name><name><surname>Vivekanandan-Giri</surname><given-names>A</given-names></name><name><surname>Gizinski</surname><given-names>A</given-names></name><name><surname>Yalavarthi</surname><given-names>S</given-names></name><name><surname>Knight</surname><given-names>JS</given-names></name><name><surname>Friday</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>RM</given-names></name><name><surname>Subramanian</surname><given-names>V</given-names></name><etal/></person-group><article-title>NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis</article-title><source>Sci Transl Med</source><volume>5</volume><fpage>178ra40</fpage><year>2013</year><pub-id pub-id-type="doi">10.1126/scitranslmed.3005580</pub-id><pub-id pub-id-type="pmid">23536012</pub-id><pub-id pub-id-type="pmcid">3727661</pub-id></element-citation></ref>
<ref id="b7-mmr-20-01-0463"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>JK</given-names></name><name><surname>Higo</surname><given-names>T</given-names></name><name><surname>Hunter</surname><given-names>WL</given-names></name><name><surname>Burt</surname><given-names>HM</given-names></name></person-group><article-title>Topoisomerase inhibitors as anti-arthritic agents</article-title><source>Inflamm Res</source><volume>57</volume><fpage>126</fpage><lpage>134</lpage><year>2008</year><pub-id pub-id-type="doi">10.1007/s00011-007-7163-6</pub-id><pub-id pub-id-type="pmid">18301866</pub-id></element-citation></ref>
<ref id="b8-mmr-20-01-0463"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bottini</surname><given-names>N</given-names></name><name><surname>Firestein</surname><given-names>GS</given-names></name></person-group><article-title>Duality of fibroblast-like synoviocytes in RA: Passive responders and imprinted aggressors</article-title><source>Nat Rev Rheumatol</source><volume>9</volume><fpage>24</fpage><lpage>33</lpage><year>2013</year><pub-id pub-id-type="doi">10.1038/nrrheum.2012.190</pub-id><pub-id pub-id-type="pmid">23147896</pub-id></element-citation></ref>
<ref id="b9-mmr-20-01-0463"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dordunoo</surname><given-names>SK</given-names></name><name><surname>Jackson</surname><given-names>JK</given-names></name><name><surname>Arsenault</surname><given-names>LA</given-names></name><name><surname>Oktaba</surname><given-names>AM</given-names></name><name><surname>Hunter</surname><given-names>WL</given-names></name><name><surname>Burt</surname><given-names>HM</given-names></name></person-group><article-title>Taxol encapsulation in poly(epsilon-caprolactone microspheres</article-title><source>Cancer Chemother Pharmacol</source><volume>36</volume><fpage>279</fpage><lpage>282</lpage><year>1995</year><pub-id pub-id-type="doi">10.1007/BF00689043</pub-id><pub-id pub-id-type="pmid">7543028</pub-id></element-citation></ref>
<ref id="b10-mmr-20-01-0463"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>JK</given-names></name><name><surname>Tudan</surname><given-names>C</given-names></name><name><surname>Sahl</surname><given-names>B</given-names></name><name><surname>Pelech</surname><given-names>SL</given-names></name><name><surname>Burt</surname><given-names>HM</given-names></name></person-group><article-title>Calcium pyrophosphate dihydrate crystals activate MAP kinase in human neutrophils: Inhibition of MAP kinase, oxidase activation and degranulation responses of neutrophils by taxol</article-title><source>Immunology</source><volume>90</volume><fpage>502</fpage><lpage>510</lpage><year>1997</year><pub-id pub-id-type="doi">10.1046/j.1365-2567.1997.d01-2178.x</pub-id><pub-id pub-id-type="pmid">9176102</pub-id><pub-id pub-id-type="pmcid">1456698</pub-id></element-citation></ref>
<ref id="b11-mmr-20-01-0463"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hui</surname><given-names>A</given-names></name><name><surname>Kulkarni</surname><given-names>GV</given-names></name><name><surname>Hunter</surname><given-names>WL</given-names></name><name><surname>McCulloch</surname><given-names>CA</given-names></name><name><surname>Cruz</surname><given-names>TF</given-names></name></person-group><article-title>Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes</article-title><source>Arthritis Rheum</source><volume>40</volume><fpage>1073</fpage><lpage>1084</lpage><year>1997</year><pub-id pub-id-type="doi">10.1002/art.1780400612</pub-id><pub-id pub-id-type="pmid">9182918</pub-id></element-citation></ref>
<ref id="b12-mmr-20-01-0463"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>JW</given-names></name><name><surname>Gao</surname><given-names>JS</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name></person-group><article-title>Resveratrol inhibits TNF-&#x03B1;-induced IL-1&#x03B2;, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase/Akt pathway</article-title><source>Rheumatol Int</source><volume>33</volume><fpage>1829</fpage><lpage>1835</lpage><year>2013</year><pub-id pub-id-type="doi">10.1007/s00296-012-2657-0</pub-id><pub-id pub-id-type="pmid">23328930</pub-id></element-citation></ref>
<ref id="b13-mmr-20-01-0463"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qui&#x00F1;onez-Flores</surname><given-names>CM</given-names></name><name><surname>Gonz&#x00E1;lez-Ch&#x00E1;vez</surname><given-names>SA</given-names></name><name><surname>Del R&#x00ED;o N&#x00E1;jera</surname><given-names>D</given-names></name><name><surname>Pacheco-Tena</surname><given-names>C</given-names></name></person-group><article-title>Oxidative stress relevance in the pathogenesis of the rheumatoid arthritis: A systematic review</article-title><source>Biomed Res Int</source><volume>2016</volume><fpage>6097417</fpage><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/6097417</pub-id><pub-id pub-id-type="pmid">27340664</pub-id><pub-id pub-id-type="pmcid">4906181</pub-id></element-citation></ref>
<ref id="b14-mmr-20-01-0463"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>G</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Inagaki</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Kokudo</surname><given-names>N</given-names></name></person-group><article-title>Anti-tumor effects and cellular mechanisms of resveratrol</article-title><source>Drug Discov Ther</source><volume>9</volume><fpage>1</fpage><lpage>12</lpage><year>2015</year><pub-id pub-id-type="doi">10.5582/ddt.2015.01007</pub-id><pub-id pub-id-type="pmid">25788047</pub-id></element-citation></ref>
<ref id="b15-mmr-20-01-0463"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakamoto</surname><given-names>T</given-names></name><name><surname>Horiguchi</surname><given-names>H</given-names></name><name><surname>Oguma</surname><given-names>E</given-names></name><name><surname>Kayama</surname><given-names>F</given-names></name></person-group><article-title>Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells</article-title><source>J Nutr Biochem</source><volume>21</volume><fpage>856</fpage><lpage>864</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.jnutbio.2009.06.010</pub-id><pub-id pub-id-type="pmid">19800779</pub-id></element-citation></ref>
<ref id="b16-mmr-20-01-0463"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alkhalaf</surname><given-names>M</given-names></name></person-group><article-title>Resveratrol-induced apoptosis is associated with activation of p53 and inhibition of protein translation in T47D human breast cancer cells</article-title><source>Pharmacology</source><volume>80</volume><fpage>134</fpage><lpage>143</lpage><year>2007</year><pub-id pub-id-type="doi">10.1159/000103253</pub-id><pub-id pub-id-type="pmid">17534123</pub-id></element-citation></ref>
<ref id="b17-mmr-20-01-0463"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>A</given-names></name><name><surname>Schulte</surname><given-names>BA</given-names></name><name><surname>Wargovich</surname><given-names>MJ</given-names></name><name><surname>Wang</surname><given-names>GY</given-names></name></person-group><article-title>Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage</article-title><source>PLoS One</source><volume>8</volume><fpage>e60065</fpage><year>2013</year><pub-id pub-id-type="doi">10.1371/journal.pone.0060065</pub-id><pub-id pub-id-type="pmid">23533664</pub-id><pub-id pub-id-type="pmcid">3606183</pub-id></element-citation></ref>
<ref id="b18-mmr-20-01-0463"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faitova</surname><given-names>J</given-names></name><name><surname>Krekac</surname><given-names>D</given-names></name><name><surname>Hrstka</surname><given-names>R</given-names></name><name><surname>Vojtesek</surname><given-names>B</given-names></name></person-group><article-title>Endoplasmic reticulum stress and apoptosis</article-title><source>Cell Mol Biol Lett</source><volume>11</volume><fpage>488</fpage><lpage>505</lpage><year>2006</year><pub-id pub-id-type="doi">10.2478/s11658-006-0040-4</pub-id><pub-id pub-id-type="pmid">16977377</pub-id><pub-id pub-id-type="pmcid">6275750</pub-id></element-citation></ref>
<ref id="b19-mmr-20-01-0463"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szegezdi</surname><given-names>E</given-names></name><name><surname>Logue</surname><given-names>SE</given-names></name><name><surname>Gorman</surname><given-names>AM</given-names></name><name><surname>Samali</surname><given-names>A</given-names></name></person-group><article-title>Mediators of endoplasmic reticulum stress-induced apoptosis</article-title><source>EMBO Rep</source><volume>7</volume><fpage>880</fpage><lpage>885</lpage><year>2006</year><pub-id pub-id-type="doi">10.1038/sj.embor.7400779</pub-id><pub-id pub-id-type="pmid">16953201</pub-id><pub-id pub-id-type="pmcid">1559676</pub-id></element-citation></ref>
<ref id="b20-mmr-20-01-0463"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mihailidou</surname><given-names>C</given-names></name><name><surname>Papazian</surname><given-names>I</given-names></name><name><surname>Papavassiliou</surname><given-names>AG</given-names></name><name><surname>Kiaris</surname><given-names>H</given-names></name></person-group><article-title>CHOP-dependent regulation of p21/waf1 during ER stress</article-title><source>Cell Physiol Biochem</source><volume>25</volume><fpage>761</fpage><lpage>766</lpage><year>2010</year><pub-id pub-id-type="doi">10.1159/000315096</pub-id><pub-id pub-id-type="pmid">20511722</pub-id></element-citation></ref>
<ref id="b21-mmr-20-01-0463"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogeski</surname><given-names>I</given-names></name><name><surname>Kilch</surname><given-names>T</given-names></name><name><surname>Niemeyer</surname><given-names>BA</given-names></name></person-group><article-title>ROS and SOCE: Recent advances and controversies in the regulation of STIM and Orai</article-title><source>J Physiol</source><volume>590</volume><fpage>4193</fpage><lpage>4200</lpage><year>2012</year><pub-id pub-id-type="doi">10.1113/jphysiol.2012.230565</pub-id><pub-id pub-id-type="pmid">22615429</pub-id><pub-id pub-id-type="pmcid">3473278</pub-id></element-citation></ref>
<ref id="b22-mmr-20-01-0463"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Cao</surname><given-names>W</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>Autophagy and mitochondrial dysfunction in adjuvant-arthritis rats treatment with resveratrol</article-title><source>Sci Rep</source><volume>6</volume><fpage>32928</fpage><year>2016</year><pub-id pub-id-type="doi">10.1038/srep32928</pub-id><pub-id pub-id-type="pmid">27611176</pub-id><pub-id pub-id-type="pmcid">5017199</pub-id></element-citation></ref>
<ref id="b23-mmr-20-01-0463"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>An</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Zong</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name></person-group><article-title>Anti-inflammatory effect of resveratrol on adjuvant arthritis rats with abnormal immunological function via the reduction of cyclooxygenase-2 and prostaglandin E2</article-title><source>Mol Med Rep</source><volume>9</volume><fpage>2592</fpage><lpage>2598</lpage><year>2014</year><pub-id pub-id-type="doi">10.3892/mmr.2014.2070</pub-id><pub-id pub-id-type="pmid">24676467</pub-id></element-citation></ref>
<ref id="b24-mmr-20-01-0463"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omatsu-Kanbe</surname><given-names>M</given-names></name><name><surname>Inoue</surname><given-names>K</given-names></name><name><surname>Fujii</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Isono</surname><given-names>T</given-names></name><name><surname>Fujita</surname><given-names>N</given-names></name><name><surname>Matsuura</surname><given-names>H</given-names></name></person-group><article-title>Effect of ATP on preadipocyte migration and adipocyte differentiation by activating P2Y receptors in 3T3-L1 cells</article-title><source>Biochem J</source><volume>393</volume><fpage>171</fpage><lpage>180</lpage><year>2006</year><pub-id pub-id-type="doi">10.1042/BJ20051037</pub-id><pub-id pub-id-type="pmid">16143005</pub-id></element-citation></ref>
<ref id="b25-mmr-20-01-0463"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>CM</given-names></name><name><surname>You</surname><given-names>YL</given-names></name><name><surname>Qian</surname><given-names>XL</given-names></name><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Ling</surname><given-names>CQ</given-names></name></person-group><article-title>Electroacupuncture ameliorates cerebral ischemia-reperfusion injury by regulation of autophagy and apoptosis</article-title><source>Evidence-Based Complement Altern Med</source><volume>2016</volume><fpage>7297425</fpage><year>2016</year><pub-id pub-id-type="doi">10.1155/2016/7297425</pub-id></element-citation></ref>
<ref id="b26-mmr-20-01-0463"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name><name><surname>Ke</surname><given-names>D</given-names></name><name><surname>Ma</surname><given-names>R</given-names></name><name><surname>Du</surname><given-names>J</given-names></name></person-group><article-title>Attenuated mesangial cell proliferation related to store-operated Ca2&#x002B; entry in aged rat: The role of STIM 1 and Orai 1</article-title><source>Age (Dordr)</source><volume>35</volume><fpage>2193</fpage><lpage>2202</lpage><year>2013</year><pub-id pub-id-type="doi">10.1007/s11357-013-9511-5</pub-id><pub-id pub-id-type="pmid">23334602</pub-id><pub-id pub-id-type="pmcid">3824990</pub-id></element-citation></ref>
<ref id="b27-mmr-20-01-0463"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>SJ</given-names></name><name><surname>Firestein</surname><given-names>GS</given-names></name><name><surname>Arsenault</surname><given-names>L</given-names></name><name><surname>Cruz</surname><given-names>TF</given-names></name><name><surname>Cheng</surname><given-names>TP</given-names></name><name><surname>Banquerigo</surname><given-names>ML</given-names></name><name><surname>Boyle</surname><given-names>DL</given-names></name><name><surname>Brahn</surname><given-names>E</given-names></name></person-group><article-title>Vanadate, an inhibitor of stromelysin and collagenase expression, suppresses collagen induced arthritis</article-title><source>J Rheumatol</source><volume>34</volume><fpage>1802</fpage><lpage>1809</lpage><year>2007</year><pub-id pub-id-type="pmid">17696279</pub-id></element-citation></ref>
<ref id="b28-mmr-20-01-0463"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HR</given-names></name><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Kim</surname><given-names>BM</given-names></name><name><surname>Lee</surname><given-names>KA</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name></person-group><article-title>N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL in rheumatoid arthritis</article-title><source>Korean J Intern Med</source><volume>34</volume><fpage>210</fpage><lpage>219</lpage><year>2019</year><pub-id pub-id-type="doi">10.3904/kjim.2016.329</pub-id><pub-id pub-id-type="pmid">28286938</pub-id></element-citation></ref>
<ref id="b29-mmr-20-01-0463"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batooei</surname><given-names>M</given-names></name><name><surname>Tahamoli-Roudsari</surname><given-names>A</given-names></name><name><surname>Basiri</surname><given-names>Z</given-names></name><name><surname>Yasrebifar</surname><given-names>F</given-names></name><name><surname>Shahdoust</surname><given-names>M</given-names></name><name><surname>Eshraghi</surname><given-names>A</given-names></name><name><surname>Mehrpooya</surname><given-names>M</given-names></name><name><surname>Ataei</surname><given-names>S</given-names></name></person-group><article-title>Evaluating the effect of oral N-acetylcysteine as an adjuvant treatment on clinical outcomes of patients with rheumatoid arthritis: A randomized, double blind clinical trial</article-title><source>Rev Recent Clin Trials</source><volume>13</volume><fpage>132</fpage><lpage>138</lpage><year>2018</year><pub-id pub-id-type="doi">10.2174/1574887113666180307151937</pub-id><pub-id pub-id-type="pmid">29521247</pub-id></element-citation></ref>
<ref id="b30-mmr-20-01-0463"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paul</surname><given-names>M</given-names></name><name><surname>Hemshekhar</surname><given-names>M</given-names></name><name><surname>Thushara</surname><given-names>RM</given-names></name><name><surname>Sundaram</surname><given-names>MS</given-names></name><name><surname>NaveenKumar</surname><given-names>SK</given-names></name><name><surname>Naveen</surname><given-names>S</given-names></name><name><surname>Devaraja</surname><given-names>S</given-names></name><name><surname>Somyajit</surname><given-names>K</given-names></name><name><surname>West</surname><given-names>R</given-names></name><name><surname>Basappa</surname></name><etal/></person-group><article-title>Methotrexate promotes platelet apoptosis via JNK-mediated mitochondrial damage: Alleviation by N-acetylcysteine and N-acetylcysteine amide</article-title><source>PLoS One</source><volume>10</volume><fpage>e0127558</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.pone.0127558</pub-id><pub-id pub-id-type="pmid">26083398</pub-id><pub-id pub-id-type="pmcid">4471342</pub-id></element-citation></ref>
<ref id="b31-mmr-20-01-0463"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name></person-group><article-title>Resveratrol induces mitochondria- mediated AIF and to a lesser extent caspase-9-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells</article-title><source>Mol Cell Biochem</source><volume>354</volume><fpage>29</fpage><lpage>37</lpage><year>2011</year><pub-id pub-id-type="doi">10.1007/s11010-011-0802-9</pub-id><pub-id pub-id-type="pmid">21505894</pub-id></element-citation></ref>
<ref id="b32-mmr-20-01-0463"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valdecantos</surname><given-names>MP</given-names></name><name><surname>P&#x00E9;rez-Matute</surname><given-names>P</given-names></name><name><surname>Quintero</surname><given-names>P</given-names></name><name><surname>Mart&#x00ED;nez</surname><given-names>JA</given-names></name></person-group><article-title>Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria: all antioxidants but different</article-title><source>Redox Rep</source><volume>15</volume><fpage>207</fpage><lpage>216</lpage><year>2010</year><pub-id pub-id-type="doi">10.1179/135100010X12826446921464</pub-id><pub-id pub-id-type="pmid">21062536</pub-id></element-citation></ref>
<ref id="b33-mmr-20-01-0463"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de la Lastra</surname><given-names>CA</given-names></name><name><surname>Villegas</surname><given-names>I</given-names></name></person-group><article-title>Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications</article-title><source>Biochem Soc Trans</source><volume>35</volume><fpage>1156</fpage><lpage>1160</lpage><year>2007</year><pub-id pub-id-type="doi">10.1042/BST0351156</pub-id><pub-id pub-id-type="pmid">17956300</pub-id></element-citation></ref>
<ref id="b34-mmr-20-01-0463"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamada</surname><given-names>R</given-names></name><name><surname>Kaminaga</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>K</given-names></name><name><surname>Yokoya</surname><given-names>A</given-names></name></person-group><article-title>Mitochondrial membrane potential morphology atp production in mammalian cells exposed to X-rays</article-title><source>Radiat Prot Dosimetry</source><month>Dec</month><day>13</day><year>2018</year><comment>doi: 10.1093/rpd/ncy254</comment><pub-id pub-id-type="pmid">30452704</pub-id></element-citation></ref>
<ref id="b35-mmr-20-01-0463"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadi</surname><given-names>G</given-names></name><name><surname>Bozan</surname><given-names>D</given-names></name><name><surname>Yildiz</surname><given-names>HB</given-names></name></person-group><article-title>Redox regulation of antioxidant enzymes: Post-translational modulation of catalase and glutathione peroxidase activity by resveratrol in diabetic rat liver</article-title><source>Mol Cell Biochem</source><volume>393</volume><fpage>111</fpage><lpage>122</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s11010-014-2051-1</pub-id><pub-id pub-id-type="pmid">24740756</pub-id></element-citation></ref>
<ref id="b36-mmr-20-01-0463"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walia</surname><given-names>V</given-names></name><name><surname>Kakar</surname><given-names>S</given-names></name><name><surname>Elble</surname><given-names>R</given-names></name></person-group><article-title>Micromanagement of the mitochondrial apoptotic pathway by p53</article-title><source>Front Biosci (Landmark Ed)</source><volume>16</volume><fpage>749</fpage><lpage>758</lpage><year>2011</year><pub-id pub-id-type="doi">10.2741/3717</pub-id><pub-id pub-id-type="pmid">21196200</pub-id></element-citation></ref>
<ref id="b37-mmr-20-01-0463"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardi</surname><given-names>P</given-names></name><name><surname>Rasola</surname><given-names>A</given-names></name></person-group><article-title>Calcium and cell death: The mitochondrial connection</article-title><source>Subcell Biochem</source><volume>45</volume><fpage>481</fpage><lpage>506</lpage><year>2007</year><pub-id pub-id-type="doi">10.1007/978-1-4020-6191-2_18</pub-id><pub-id pub-id-type="pmid">18193649</pub-id></element-citation></ref>
<ref id="b38-mmr-20-01-0463"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>W</given-names></name><name><surname>Tan</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>Ghrelin prevents doxorubicin-induced cardiotoxicity through TNF-alpha/NF-kappaB pathways and mitochondrial protective mechanism</article-title><source>Toxicology</source><volume>247</volume><fpage>133</fpage><lpage>138</lpage><year>2008</year><pub-id pub-id-type="doi">10.1016/j.tox.2008.02.018</pub-id><pub-id pub-id-type="pmid">18400355</pub-id></element-citation></ref>
<ref id="b39-mmr-20-01-0463"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Contreras</surname><given-names>L</given-names></name><name><surname>Drago</surname><given-names>I</given-names></name><name><surname>Zampese</surname><given-names>E</given-names></name><name><surname>Pozzan</surname><given-names>T</given-names></name></person-group><article-title>Mitochondria: The calcium connection</article-title><source>Biochim Biophys Acta1</source><volume>797</volume><fpage>607</fpage><lpage>618</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.bbabio.2010.05.005</pub-id></element-citation></ref>
<ref id="b40-mmr-20-01-0463"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fels</surname><given-names>DR</given-names></name><name><surname>Koumenis</surname><given-names>C</given-names></name></person-group><article-title>The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth</article-title><source>Cancer Biol Ther</source><volume>5</volume><fpage>723</fpage><lpage>728</lpage><year>2006</year><pub-id pub-id-type="doi">10.4161/cbt.5.7.2967</pub-id><pub-id pub-id-type="pmid">16861899</pub-id></element-citation></ref>
<ref id="b41-mmr-20-01-0463"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>J</given-names></name><name><surname>Kong</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Yu</surname><given-names>C</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Yi</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><article-title>IInhibition of CLIC4 enhances autophagy and triggers mitochondrial and ER stress-induced apoptosis in human glioma U251 cells under starvation</article-title><source>PLoS One</source><volume>7</volume><fpage>e39378</fpage><year>2012</year><pub-id pub-id-type="doi">10.1371/journal.pone.0039378</pub-id><pub-id pub-id-type="pmid">22761775</pub-id><pub-id pub-id-type="pmcid">3382619</pub-id></element-citation></ref>
<ref id="b42-mmr-20-01-0463"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xue</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name></person-group><article-title>Knockdown of CLIC4 enhances ATP-induced HN4 cell apoptosis through mitochondrial and endoplasmic reticulum pathways</article-title><source>Cell Bio</source><volume>6</volume><fpage>5</fpage><year>2016</year></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-mmr-20-01-0463" position="float">
<label>Figure 1.</label>
<caption><p>Representative histograms showing the (A) degree of paw swelling and (B) arthritis score in grouped Sprague-Dawley rats following intragastric administration of the respective drugs. (C) Hematoxylin and eosin staining of the knee joints in grouped adjuvant arthritis rats following intragastric administration. Specific pathological features in the model group and 45 mg/kg Res-treatment group are labeled with red arrows (magnification of expanded images, &#x00D7;400). Data are shown as the mean &#x00B1; standard deviation. &#x002A;P&#x003C;0.05, vs. control; <sup>#</sup>P&#x003C;0.05 vs. model (n=10/group). Res, resveratrol; NAC, <italic>N</italic>-acetyl-L-cysteine; F1/F0, fluorescence density pre-/post-agonist administration.</p></caption>
<graphic xlink:href="MMR-20-01-0463-g00.tif"/>
</fig>
<fig id="f2-mmr-20-01-0463" position="float">
<label>Figure 2.</label>
<caption><p>Res alleviates inflammatory injury in adjuvant arthritis rats and triggers apoptosis in FLSs. Representative histograms show the serum levels of (A) IL-1, (B) IL-6, (C) IL-8, (D) IL-10 and (E) TNF-&#x03B1;, from all grouped rats detected via ELISA assay. (F) Quantified data and (G) images (magnification, &#x00D7;400) showing the apoptotic rates of FLSs following Res and H<sub>2</sub>O<sub>2</sub> treatment, detected via terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling assay. The apoptotic rate was determined by apoptotic cell number/total cell number. (H) Representative images (magnification, &#x00D7;400) show the intracellular reactive oxygen species levels in FLSs, detected via DCFH-DA following Res and H<sub>2</sub>O<sub>2</sub> treatment. Data are shown as the mean &#x00B1; standard deviation. &#x002A;P&#x003C;0.05, vs. control; <sup>#</sup>P&#x003C;0.05, <sup>##</sup>P&#x003C;0.01, vs. model (n=10/group). FLSs, fibroblast-like synoviocytes; Res, resveratrol; NAC, <italic>N</italic>-acetyl-L-cysteine; IL, interleukin; TNF-&#x03B1;, tumor necrosis factor-&#x03B1;; DCFH-DA, 2&#x2032;,7&#x2032;-dichlorodihydrofluorescein diacetate.</p></caption>
<graphic xlink:href="MMR-20-01-0463-g01.tif"/>
</fig>
<fig id="f3-mmr-20-01-0463" position="float">
<label>Figure 3.</label>
<caption><p>Mitochondrial dysfunction is involved in the process of Res-induced apoptosis in FLSs. (A) &#x0394;&#x03C8;m was determined using confocal laser scanning microscopy and images were captured (magnification, &#x00D7;400). Red fluorescence represents JC-1 aggregates in matrix of mitochondria, whereas green fluorescence represents JC-1 monomers, indicating a decreased &#x0394;&#x03C8;m. Merged images show the overlap of JC-1 aggregates and monomers. (B) &#x0394;&#x03C8;m in each group is presented as the red/green fluorescence. In addition, FLSs were lysed and prepared for immunoblotting. (C) Representative images and data showing the expression levels of (D) active caspase-3, (E) Bcl-2 and (F) Bax. Data are shown as the mean &#x00B1; standard deviation. &#x002A;P&#x003C;0.05, vs. control. &#x0394;&#x03C8;m, mitochondrial membrane potential; FLSs, fibroblast-like synoviocytes; Res, resveratrol; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein.</p></caption>
<graphic xlink:href="MMR-20-01-0463-g02.tif"/>
</fig>
<fig id="f4-mmr-20-01-0463" position="float">
<label>Figure 4.</label>
<caption><p>Suppression of [Ca<sup>2&#x002B;</sup>]<sub>i</sub> release and endoplasmic reticulum stress in FLSs are involved in the process of Res-induced apoptosis in FLSs. (A) Representative traces and (B) quantification of data, showing the elevation in [Ca<sup>2&#x002B;</sup>]<sub>i</sub> induced by 2 &#x00B5;mol/l TG-induced FLSs in Ca<sup>2&#x002B;</sup>-free saline solution. (C) Representative traces and (D) quantification of data, showing the elevation in [Ca<sup>2&#x002B;</sup>]<sub>i</sub> induced by 100 &#x00B5;mol/l ATP-induced FLSs in Ca<sup>2&#x002B;</sup>-free saline solution. Changes in [Ca<sup>2&#x002B;</sup>]<sub>i</sub> were indicated by the ratio of the fluorescence density prior to and following administration of the agonists (F1/F0). (E) Representative images and data showing the expression levels of (F) Chop and (G) caspase-12. Data are shown as the mean &#x00B1; standard error of the mean. &#x002A;P&#x003C;0.05, vs. control group. Res, resveratrol; [Ca<sup>2&#x002B;</sup>]<sub>i</sub>, intracellular calcium concentration; TG, thapsigargin; FLSs, fibroblast-like synoviocytes; Chop, C/EBP-homologous protein.</p></caption>
<graphic xlink:href="MMR-20-01-0463-g03.tif"/>
</fig>
<fig id="f5-mmr-20-01-0463" position="float">
<label>Figure 5.</label>
<caption><p>Graphic abstract, illustrating how resveratrol alleviates inflammatory injury and enhances the apoptosis of FLSs via mitochondrial dysfunction and ER stress in AA rats. AA, adjuvant arthritis; FCA, Freund&#x0027;s complete adjuvant; FLSs, fibroblast-like synoviocytes; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2-associated X protein; ER, endoplasmic reticulum; Chop, C/EBP-homologous protein; MMP, matrix metalloproteinase.</p></caption>
<graphic xlink:href="MMR-20-01-0463-g04.tif"/>
</fig>
</floats-group>
</article>